Meronem, known generically as meropenem, is a broad-spectrum antibiotic belonging to the carbapenem class of beta-lactam antibiotics. It is specifically designed to treat a wide range of severe bacterial infections, including those affecting the lungs (pneumonia), urinary tract, skin, and abdominal organs. Meropenem works by inhibiting cell wall synthesis in bacteria, leading to cell death and the resolution of the infection. It is particularly valued for its effectiveness against Gram-positive, Gram-negative, and anaerobic bacteria, making it a critical option in the treatment of infections that are resistant to other antibiotics. Meronem is typically administered intravenously in a hospital setting, ensuring that it is used under medical supervision due to its potent nature and the potential for resistance development.